Showing results (31-40 of 308) with videos related to
Sort By:
Pageof 31
BMC Medical Research Methodology|July 21, 2017
A random effects meta-analysis model with Box-Cox transformationYusuke Yamaguchi, Kazushi Maruo, Christopher Partlett, et al.Biostatistics (Oxford, England)|July 13, 2007
An alternative model for bivariate random-effects meta-analysis when the within-study correlations are unknownRichard D Riley, John R Thompson, Keith R AbramsStatistics in Medicine|April 26, 2012
A multivariate meta-analysis approach for reducing the impact of outcome reporting bias in systematic reviewsJamie J Kirkham, Richard D Riley, Paula R WilliamsonJournal of Clinical Epidemiology|November 27, 2010
Statistical methods can be improved within Cochrane pregnancy and childbirth reviewsRichard D Riley, Simon Gates, James Neilson, et al.Breast Cancer Research : BCR|September 13, 2012
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genesMuhammad Riaz, Anieta M Sieuwerts, Maxime P Look, et al.Head & Neck|December 14, 2006
Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinomaLuciënne Speleman, Jeroen D F Kerrebijn, Maxime P Look, et al.Statistical Methods in Medical Research|June 28, 2015
Performance of methods for meta-analysis of diagnostic test accuracy with few studies or sparse dataYemisi Takwoingi, Boliang Guo, Richard D Riley, et al.Statistical Methods in Medical Research|February 7, 2017
Deriving percentage study weights in multi-parameter meta-analysis models: with application to meta-regression, network meta-analysis and one-stage individual participant data modelsRichard D Riley, Joie Ensor, Dan Jackson, et al.Oncotarget|April 16, 2016
Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosisMarjolein J A Weerts, Anieta M Sieuwerts, Marcel Smid, et al.Clinical Breast Cancer|December 9, 2004
Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancerNadia Harbeck, Roanld E Kates, Manfred Schmitt, et al.Pageof 31